HALO
Halozyme Therape (HALO)
NASDAQ
$124.55+$0.005 (+0.004%)
Price as of Oct 22, 2026 7:43 PM EDT
  • $14.2B
    Market Cap
  • 86.20%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 62
Valuation
HALO
vs History
vs S&P 500
Profitability
0
Growth
-0
Low Earnings Volatility
1

Momentum Score

Score: 83
Valuation
HALO
vs History
vs S&P 500
3-Month Momentum
44.49%
12-Month Momentum
70.96%
3-Month Risk Adjusted Momentum
197.04%
12-Month Risk Adjusted Momentum
196.41%

True Yield

N/A
Valuation
HALO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.42%
Net Debt Paydown Yield
-0.03%

Financial Health Score

Score: 42
Valuation
HALO
vs History
vs S&P 500
Ohlson's O-Score
6